Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FlashLyte: Bitopertin for Negative Symptoms of Schizophrenia
NCT01192867Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2010
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of bitopertin in schizophrenia, sponsored by Roche. Started Dec 2010; status: completed.
02
Drugs
bitopertin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01192867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192867.